Table 1.
Characteristics of the tumors analyzed.
| Sample # | Tumorlocation | IgHrearrangement | TCRrearrangement | Histological abnormalities | BCR/TCR-based tumor type |
|---|---|---|---|---|---|
| 91 (control) | Spleen | N/A | N/A | None | N/A |
| 92 (control) | Spleen | N/A | N/A | None | N/A |
| 93 (control) | Spleen | N/A | N/A | None | N/A |
| MPr14-111 | Lymph node | No | No | LL | Common Lymphoid Progenitor (CLP)-like |
| MPr14-143 | Spleen | Yes | No | LL with erythroblastosis | Precursor-B |
| MPr14-147 | Spleen | Yes | Yes | LL | Mixed |
| MPr14-148 | Lymph node | No | Yes | LL with erythroblastosis | Precursor-T |
| MPr14-185 | Lymph node | Yes | No | LL | Precursor-B |
| MPr14-189 | Lymph node | Yes | No | LL | Precursor-B |
| MPr14-196 | Spleen | Unknown | Unknown | LL with erythroblastosis | Unclassified |
| MPr14-197 | Spleen | Yes | Yes | LL | Mixed |
| MPr14-217 | Lymph node | Yes | No | LL | Precursor-B |
| MPr14-218 | Lymph node | Yes | No | LL-pleiomorphic | Precursor-B |
| MPr14-228 | Spleen | Yes | Yes | LL with increased megakaryocytes | Mixed |
| MPr14-258 | Spleen | No | Yes | LL | Precursor-T |
LL = lymphoblastic lymphoma. N/A = not applicable.